May Sara R. 4

What Happened
May Sara R., a director of Medicus Pharma Ltd. (MDCX), received a derivative award on 2026-06-03: a 50,000-share option reported at an acquisition price of $0.00 (no cash paid at grant). This is an award/option grant (a common retention/incentive action), not a sale.

Key Details

• Transaction date: 2026-06-03; Form 4 filed 2026-06-04 (appears timely).
• Instrument: Option grant for 50,000 shares; reported acquisition price $0.00.
• Vesting: Scheduled to vest quarterly in four equal installments over one year (per footnote).
• Shares owned after transaction: Not specified in the provided filing.
• Filing accession: 0000950142-26-001639.
• Transaction type code on Form 4: A = Award/Grant (derivative).

Context
This was a grant of options (a derivative award), meaning the insider received the right to acquire shares subject to vesting—no shares were sold or exercised in this filing. Such grants are typically used for compensation or retention and do not by themselves indicate immediate buying or selling pressure.